Le Lézard
Classified in: Health
Subjects: AWD, LAW

$120 Million Verdict Against Westchester Medical Center


NEW YORK, Dec. 4, 2023 /PRNewswire/ -- On November 30, 2023, following a four-week trial before the Honorable Paul I. Marx, a Westchester County jury returned a record-setting $120 million medical malpractice verdict against Westchester Medical Center. 

The jury determined that the hospital's failure to timely diagnose and treat 41-year-old William Lee, who was rushed in by ambulance on November 27, 2018 while he was suffering from a stroke, caused extensive brain damage, requiring his lifelong confinement to a residential brain injury center. Mr. Lee was represented by lead trial attorney Ben Rubinowitz who along with Jeffrey Bloom and Richard Steigman of the Manhattan Personal Injury Law Firm of Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf, made clear that inexperienced doctors who were on call at the hospital were responsible for a 3-hour delay in removing the clot from Mr. Lee's basilar artery, while overcoming the Hospital's argument that due to the nature of the blockage, his brain damage had already occurred before he was admitted to the hospital. 

Mr. Lee's injuries have decimated portions of his brain that control judgment and short-term memory, rendering him unable to live independently and to provide for his wife and children. The jury's verdict included awards for Mr. Lee's future medical needs, his pain and suffering, and loss of enjoyment of life, as well as awards for his wife's loss of his services and society. The verdict represents the largest award ever in a medical malpractice case in Westchester County.

The NYC medical malpractice attorneys at Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf bring over a century of collective experience in representing patients harmed or fatally injured due to healthcare negligence. This esteemed team includes multiple lawyers recognized in Best Lawyers in America, notably managing partner Ben Rubinowitz recognized 6 times "Lawyer of the Year". Richard Steigman was awarded "Lawyer of the Year" for Medical Malpractice Law - Plaintiffs in New York City in 2022. Jeffrey Bloom co-chairs the Medical Malpractice Committee of the New York State Trial Lawyers Association.

Their track record in securing justice for victims is impressive, with landmark settlements and verdicts. Notably, they achieved a significant confidential settlement in the Joan Rivers Medical Malpractice Case.

CONTACT: Ben Rubinowitz, [email protected], 212-943-1090

SOURCE Gair, Gair, Conason, Rubinowitz, Bloom, Hershenhorn, Steigman & Mackauf


These press releases may also interest you

at 07:30
Canopy Growth Corporation ("Canopy Growth" or the "Company") , today announced that on May 2, 2024, it entered into an exchange and subscription agreement (the "Agreement") with a single institutional investor (the "Investor") pursuant to which...

at 07:17
In a heartfelt message in the heart of spring, Kevin Guest, executive chairman at USANA Health Sciences , shares his insights and support for May's Family Wellness Month, an initiative that highlights the importance of family health and unity....

at 07:10
10 Barrel Brewing Co. ("10 Barrel Brewing Co." or "10 Barrel"), a Pacific Northwestern pioneer in craft brewing, a subsidiary of Tilray Brands, Inc. , unveils its latest creation: Pub Cerveza. Building upon the legacy of the ?Cheap Fun.' family,...

at 07:05
Fulgent Genetics, Inc. ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced financial results for its first quarter ended March 31,...

at 07:05
2seventy bio, Inc. will announce its first quarter 2024 financial results on Wednesday, May 8, 2024. A conference call and webcast will be held at 8:00 a.m. ET. Participants can access the conference call live via webcast which will be available...

at 07:05
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that new data supporting the utility of its DecisionDx-SCC test in patients with high-risk cutaneous squamous cell carcinoma (SCC)...



News published on and distributed by: